SUMMARYSpirulina is free-floating filamentous microalgae growing in alkaline water bodies. With its high nutritional value, Spirulina has been consumed as food for centuries in Central Africa. It is now widely used as nutraceutical food supplement worldwide. Recently, great attention and extensive studies have been devoted to evaluate its therapeutic benefits on an array of diseased conditions including hypercholesterolemia, hyperglycerolemia, cardiovascular diseases, inflammatory diseases, cancer, and viral infections. The cardiovascular benefits of Spirulina are primarily resulted from its hypolipidemic, antioxidant, and antiinflammatory activities. Data from preclinical studies with various animal models consistently demonstrate the hypolipidemic activity of Spirulina. Although differences in study design, sample size, and patient conditions resulting in minor inconsistency in response to Spirulina supplementation, the findings from human clinical trials are largely consistent with the hypolipidemic effects of Spirulina observed in the preclinical studies. However, most of the human clinical trials are suffered with limited sample size and some with poor experimental design. The antioxidant and/or antiinflammatory activities of Spirulina were demonstrated in a large number of preclinical studies. However, a limited number of clinical trials have been carried out so far to confirm such activities in human. Currently, our understanding on the underlying mechanisms for Spirulina's activities, especially the hypolipidemic effect, is limited. Spirulina is generally considered safe for human consumption supported by its long history of use as food source and its favorable safety profile in animal studies. However, rare cases of side-effects in human have been reported. Quality control in the growth and process of Spirulina to avoid contamination is mandatory to guarantee the safety of Spirulina products.

The prokaryotic Synechococcus sp. RF-1 exhibited a nitrogen fixation circadian rhythm with characteristics remarkably similar to the circadian rhythm of eukaryotes. The rhythm had a freerunning period of about 24 hours when the length of the preentrained cycle did not differ too much from 24 hours, and it was insensitive to changes in temperature from 220C to 330C. Because the endogenous rhythm of nitrogen fixation was not affected by a phase-shift of its previous cycles, the circadian rhythm in Synechococcus sp. RF-1 was not considered to be controlled simply by a feedback mechanism.medium (13)

Synechococcus sp. strain RF-1 exhibits a circadian rhythm of N2 fixation when cells are grown under a light-dark cycle, with nitrogenase activity observed only during the dark period. This dark-dependent activity correlated with nif gene transcription in strain RF-1. By using antibodies against dinitrogenase reductase (the Fe protein of the nitrogenase complex), it was found that there was a distinct shift in the mobility of this protein on sodium dodecyl sulfate gels during the light-dark cycle. The Fe protein was present only when cells were incubated in the dark. Upon illumination, there was a conversion of all Fe protein to a modified form, after which it rapidly disappeared from extracts. These studies indicated that all nitrogenase activity present during the dark cycle resulted from de novo synthesis of nitrogenase. Upon entering the light phase, cells appeared to quickly degrade the modified form of Fe protein, perhaps as a result of activating or inducing a protease. By contrast, transcription of the rbcL gene, which encodes the catalytic subunit of the key enzyme of CO2 fixation (a light-dependent process), was enhanced in the light.

Under continuous illumination this unicellular aerobic cyanobacterium fixes dinitrogen continuously at a variable and usually low rate. Exposure of the culture to diurnal light/dark cycles invariably results in the virtual restriction of nitrogenase activity to the dark periods. The rhythmic diurnal dinitrogen fixation pattern becomes a truely endogenous cycle which persists for at least 4 days with decreasing magnitude on exposing the culture to continuous illumination. The free running time of the rhythm appears to decrease from an initial 26 h to 22 h in the course of 4 days. This appears to be the first record of an endogenous rhythm in a prokaryote.

No abstract